A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

February 28, 2031

Study Completion Date

February 28, 2031

Conditions
Chronic Graft Versus Host Disease
Interventions
DRUG

Belumosudil

Pharmaceutical form:Oral suspension -Route of administration:Oral or nasogastric tube

DRUG

Belumosudil

Pharmaceutical form:Tablet formulation-Route of administration:Oral

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY